<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04936347</url>
  </required_header>
  <id_info>
    <org_study_id>Z191100006619058</org_study_id>
    <nct_id>NCT04936347</nct_id>
  </id_info>
  <brief_title>Hysteroscopic &quot;Hot Knife&quot; and &quot;Cold Knife&quot; in the Treatment of the Intrauterine Adhesion</brief_title>
  <official_title>A Randomized Controlled Study of Bipolar Electric Cutting and Scissors Under Hysteroscopy in the Treatment of the Intrauterine Adhesion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fu Xing Hospital, Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fu Xing Hospital, Capital Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective, randomized controlled trial，the investigators wish to explore the&#xD;
      difference of therapeutic effect and prognosis between &quot;hot knife&quot; and &quot;cold knife&quot; in the&#xD;
      treatment of uterine adhesion under hysteroscopy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Study Design：This is a prospective, randomized controlled trial.The investigators use&#xD;
           hysteroscopy finding as standard reference.&#xD;
&#xD;
        2. Study population 802 patients diagnosed with intrauterine adhesions（IUA）will be&#xD;
           prospectively recruited. Before the surgery all patients will undergo preoperative&#xD;
           evaluations, including a detailed history of the menstrual pattern,any previous&#xD;
           intrauterine surgery, and reproductive history, as well as trans-vaginal&#xD;
           ultrasonography.The severity and extent of intrauterine adhesions will be scored&#xD;
           according to the ESGE IUA grades.&#xD;
&#xD;
        3. Randomization:&#xD;
&#xD;
           Randomization was performed electronically using SPSS statistical software version 26.0&#xD;
           (SPSS, Inc., Chicago, IL,USA) by the investigator.802 recruited patients will be&#xD;
           randomized to one of the two treatment groups by computer-generated numbers: the control&#xD;
           group(&quot;hot knife&quot; group) and the experimental group(&quot;cold knife&quot; group).&#xD;
&#xD;
        4. Surgical technique:&#xD;
&#xD;
             -  Hysteroscopic surgery will be performed in a standardized manner.The procedure will&#xD;
                be performed under general anesthesia. Ultrasonographic guidance will be routinely&#xD;
                used.&#xD;
&#xD;
             -  The interference of &quot;cold knife&quot; group (the experimental group) including 401 IUA&#xD;
                patients is to perform intrauterine adhesiolysis with scissors, while the&#xD;
                interference of &quot;hot knife&quot; group (the control group) is to perform intrauterine&#xD;
                adhesiolysis with bipolar electric needle electrode, part of the scar tissue&#xD;
                removed by electronic loop when it is necessary.&#xD;
&#xD;
             -  A Foley-catheter filled with 3.0-5.0 ml normal saline will be inserted into the&#xD;
                uterus for 5-7 days after surgery.&#xD;
&#xD;
        5. Postoperative treatments&#xD;
&#xD;
             -  All subjects will be treated with oral antibiotics for 5-7 days.&#xD;
&#xD;
             -  All subjects will be treated with Hormone therapy.&#xD;
&#xD;
             -  A second-look hysteroscopy will be carried out in the early proliferative phase 4&#xD;
                weeks after the surgery and an optional third-look hysteroscopy will be carried out&#xD;
                8 weeks after the surgery.&#xD;
&#xD;
        6. Follow up:&#xD;
&#xD;
             -  Follow-up styles: the doctor's outpatient review, telephone, WeChat and so on.&#xD;
&#xD;
             -  Follow-up time:1 month, 2months, 12 months after the operation.&#xD;
&#xD;
             -  Follow up the results of hysteroscopy and the menstrual improvement and pregnancy&#xD;
                outcomes at 12 months after the operation.&#xD;
&#xD;
        7. Consent： All subjects will be given a detailed explanation of the study and sufficient&#xD;
           time to consider their participation. A written consent form will be signed by the&#xD;
           patient and retained in the records.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>2 months after surgery</time_frame>
    <description>Recurrence rate of intrauterine adhesions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>1 year after the patient desire for pregnancy</time_frame>
    <description>The conception rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Menstrual improvement rate</measure>
    <time_frame>2 months after surgery</time_frame>
    <description>The patients' estrual improvement rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">802</enrollment>
  <condition>Intrauterine Adhesion</condition>
  <arm_group>
    <arm_group_label>Cold knife</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The interference of the experimental group is to perform intrauterine adhesiolysis with scissors</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hot knife</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The interference of the control group is to perform intrauterine adhesiolysis with bipolar electric needle electrode, part of the scar tissue removed by electronic loop when it is necessary.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cold knife</intervention_name>
    <description>Transcervical resection of adhesions is performed with scissors to restore the shape of uterine cavity, promote the regeneration and repair of endometrium, and ultimately improve the reproductive prognosis of patients.</description>
    <arm_group_label>Cold knife</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>hot knife</intervention_name>
    <description>Transcervical resection of adhesions is performed with bipolar electric cutting to restore the shape of uterine cavity, promote the regeneration and repair of endometrium, and ultimately improve the reproductive prognosis of patients.</description>
    <arm_group_label>Hot knife</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indications: fertility desire, periodic pelvic pain;&#xD;
&#xD;
          -  Women aged 18-40 years;&#xD;
&#xD;
          -  Moderate to severe intrauterine adhesion(ESGE Grade II-IV);&#xD;
&#xD;
          -  All enrolled women provided written informed consent and agree to the entire study&#xD;
             protocol prior to surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications: such as severe medical diseases, pregnancy status, reproductive&#xD;
             tract infection, malignant tumor;&#xD;
&#xD;
          -  History of uterine artery embolization;&#xD;
&#xD;
          -  Infertility caused by male factors or ovarian dysfunction or premature ovarian failure&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tinchiu Li</last_name>
    <role>Study Chair</role>
    <affiliation>Fuxing Hospital,Capital Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaowu Huang</last_name>
    <phone>+8613810828816</phone>
    <email>hxiaowu_fxyy@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fu Xing Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <zip>100038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>luo wen</last_name>
      <phone>+86 010-88062291</phone>
      <email>fxyykjk@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg. 2017;14(1):6. doi: 10.1186/s10397-017-1007-3. Epub 2017 May 1.</citation>
    <PMID>28603474</PMID>
  </reference>
  <reference>
    <citation>Guo EJ, Chung JPW, Poon LCY, Li TC. Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review. Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114. doi: 10.1016/j.bpobgyn.2018.12.009. Epub 2019 Jan 3.</citation>
    <PMID>30713131</PMID>
  </reference>
  <reference>
    <citation>Valle RF, Sciarra JJ. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988 Jun;158(6 Pt 1):1459-70.</citation>
    <PMID>3381869</PMID>
  </reference>
  <reference>
    <citation>Yu D, Wong YM, Cheong Y, Xia E, Li TC. Asherman syndrome--one century later. Fertil Steril. 2008 Apr;89(4):759-79. doi: 10.1016/j.fertnstert.2008.02.096. Review.</citation>
    <PMID>18406834</PMID>
  </reference>
  <reference>
    <citation>Khan Z, Goldberg JM. Hysteroscopic Management of Asherman's Syndrome. J Minim Invasive Gynecol. 2018 Feb;25(2):218-228. doi: 10.1016/j.jmig.2017.09.020. Epub 2017 Oct 9. Review.</citation>
    <PMID>29024798</PMID>
  </reference>
  <results_reference>
    <citation>Hooker AB, Lemmers M, Thurkow AL, Heymans MW, Opmeer BC, Brölmann HA, Mol BW, Huirne JA. Systematic review and meta-analysis of intrauterine adhesions after miscarriage: prevalence, risk factors and long-term reproductive outcome. Hum Reprod Update. 2014 Mar-Apr;20(2):262-78. doi: 10.1093/humupd/dmt045. Epub 2013 Sep 29. Review.</citation>
    <PMID>24082042</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fu Xing Hospital, Capital Medical University</investigator_affiliation>
    <investigator_full_name>Xiaowu Huang</investigator_full_name>
    <investigator_title>Director of department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

